Loss of tissue transglutaminase as a biomarker for prostate adenocarcinoma

Cancer

Volumn 89, Issue 2, 2000, Pages 412-423

  Birckbichler, Paul J ^a,b   Bonner, Rebecca B ^a   Hurst, Robert E ^a,c   Bane, Barbara L ^a,d   Pitha, Jan V ^a,d   Hemstreet III, George P ^a,c,d  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b SLIPPERY ROCK UNIVERSITY   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Benign prostatic hyperplasia; Biomarker; Case control studies; Protein glutamine gamma glutamyltransferase; Quantitative fluorescence image analysis; Quantitative immunohistochemistry; Surrogate endpoint marker; Transglutaminase

Indexed keywords

AZACITIDINE; PROSTATE SPECIFIC ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER SCREENING; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE MARKER; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; PROSTATITIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROSTATITIS; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TRANSGLUTAMINASES; TUMOR MARKERS, BIOLOGICAL;

EID: 0034662028     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000715)89:2<412::AID-CNCR29>3.0.CO;2-O     Document Type: Article

References (48)